The abstract is read at the publisher; the summary is JClub's.
H3H homologues from Neonothopanus nambi and Mycena chlorophos show pronounced substrate inhibition by hispidin, and H3H strongly prefers hispidin over 3-hydroxyhispidin.
- Why it matters: Limited biochemical characterization of fungal bioluminescence enzymes constrains understanding and engineering of pathway flux for bioimaging and synthetic biology.
- What they did: The authors purified recombinant luciferase (Luz) and hispidin-3-hydroxylase (H3H) homologues and used luminescence and mass spectrometry assays plus direct substrate-turnover monitoring.
- The result: They found NADPH- and FAD-dependent secondary H3H conversion of 3-hydroxyhispidin producing multiple downstream products, including caffeic acid, enabling a biochemical framework for pathway engineering.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.